Oleanolic acid inhibits epithelial–mesenchymal transition of hepatocellular carcinoma by promoting iNOS dimerization
Oleanolic acid exhibits extensive pharmacologic activities and takes significant antitumor
effects. Its pharmacologic mechanism, however, still remained to be further clarified. In this …
effects. Its pharmacologic mechanism, however, still remained to be further clarified. In this …
Sorafenib: activity and clinical application in patients with hepatocellular carcinoma
YS Guan, Q He - Expert opinion on pharmacotherapy, 2011 - Taylor & Francis
Introduction: Sorafenib is a novel oral bis-aryl urea compound that has proven survival
benefit in patients with advanced hepatocellular carcinoma (HCC), for which several …
benefit in patients with advanced hepatocellular carcinoma (HCC), for which several …
A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis
M Ikeda, T Okusaka, J Furuse, S Mitsunaga… - Cancer chemotherapy …, 2013 - Springer
Purpose The objective of this study was to evaluate the response rate, survival, and adverse
effects of hepatic arterial infusion chemotherapy (HAIC) using cisplatin in patients with …
effects of hepatic arterial infusion chemotherapy (HAIC) using cisplatin in patients with …
[HTML][HTML] Lenalidomide improvement of cisplatin antitumor efficacy on triple-negative breast cancer cells in vitro
LL Yin, XM Wen, QH Lai, J Li… - Oncology …, 2018 - spandidos-publications.com
Lenalidomide is an immunomodulatory drug and possesses anti-angiogenic and
immunomodulatory activities against multiple myeloma. The present study assessed the in …
immunomodulatory activities against multiple myeloma. The present study assessed the in …
Bufalin enhances the anti-proliferative effect of sorafenib on human hepatocellular carcinoma cells through downregulation of ERK
Y Gao, HX Li, LT Xu, P Wang, LY Xu, L Cohen… - Molecular biology …, 2012 - Springer
The purpose of this study was to investigate the effect of bufalin on the anti-proliferative
activity of sorafenib in the human hepatocellular carcinoma (HCC) cell lines PLC/PRF/5 and …
activity of sorafenib in the human hepatocellular carcinoma (HCC) cell lines PLC/PRF/5 and …
[HTML][HTML] Effect of sorafenib combined with cytostatic agents on hepatoblastoma cell lines and xenografts
C Eicher, A Dewerth, J Thomale, V Ellerkamp… - British journal of …, 2013 - nature.com
Background: Sorafenib has recently been shown to reduce tumour growth in
hepatoblastoma (HB) xenografts. The effect of a combined administration with cytostatic …
hepatoblastoma (HB) xenografts. The effect of a combined administration with cytostatic …
Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinoma
A Hagihara, M Ikeda, H Ueno, C Morizane… - Cancer …, 2014 - Wiley Online Library
The aims of this study were to evaluate the frequency of dose‐limiting toxicities and to find
the recommended dose of combination chemotherapy with sorafenib and transcatheter …
the recommended dose of combination chemotherapy with sorafenib and transcatheter …
Phase I study of sorafenib in combination with intermittent hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma
M Ishizaki, M Kaibori, K Matsui, H Ikeda… - Cancer …, 2017 - Taylor & Francis
Objectives: We conducted a phase I study of sorafenib and intermittent hepatic arterial
infusion chemotherapy using cisplatin for unresectable hepatocellular carcinoma. Methods …
infusion chemotherapy using cisplatin for unresectable hepatocellular carcinoma. Methods …